Latest News about NBIX
Recent news which mentions NBIX
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
September 26, 2022
From Benzinga
3 Growth Stocks That Are Crushing It This Year
September 10, 2022
From Motley Fool
Neurocrine Biosciences Buys UK-Based Hormone Therapy Player
August 30, 2022
Tickers
NBIX
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
From Benzinga
Neurocrine Biosciences (NBIX) Q2 2022 Earnings Call Transcript
August 05, 2022
Tickers
NBIX
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Tickers
NBIX
From Motley Fool
Neurocrine Biosciences Q1 2022 Earnings Conference Call On May 4, 2022 At 08:00 AM ET
April 25, 2022
Tickers
NBIX
From Benzinga
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
February 25, 2022
From Benzinga
Looking Into Neurocrine Biosciences's Return On Capital Employed
February 14, 2022
Tickers
NBIX
From Benzinga
Neurocrine Biosciences (NBIX) Q4 2021 Earnings Call Transcript
February 11, 2022
Tickers
NBIX
From Motley Fool
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
From Benzinga
Earnings Scheduled For February 11, 2022
February 11, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
From Benzinga
10 Biggest Price Target Changes For Tuesday
January 18, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.